PMC:7205724 / 497-591
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"11","span":{"begin":2,"end":10},"obj":"Disease"},{"id":"17","span":{"begin":36,"end":39},"obj":"Gene"},{"id":"19","span":{"begin":63,"end":71},"obj":"Species"},{"id":"20","span":{"begin":15,"end":26},"obj":"Chemical"},{"id":"21","span":{"begin":77,"end":85},"obj":"Disease"}],"attributes":[{"id":"A11","pred":"tao:has_database_id","subj":"11","obj":"MESH:C000657245"},{"id":"A17","pred":"tao:has_database_id","subj":"17","obj":"Gene:3569"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"Tax:9606"},{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"MESH:C502936"},{"id":"A21","pred":"tao:has_database_id","subj":"21","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"f COVID-19.\n• Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T4","span":{"begin":2,"end":10},"obj":"Disease"},{"id":"T5","span":{"begin":77,"end":85},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"f COVID-19.\n• Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high"}
LitCovid-sample-PD-NCBITaxon
{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T4","span":{"begin":2,"end":10},"obj":"Species"},{"id":"T5","span":{"begin":77,"end":85},"obj":"Species"}],"attributes":[{"id":"A4","pred":"ncbi_taxonomy_id","subj":"T4","obj":"NCBItxid:2697049"},{"id":"A5","pred":"ncbi_taxonomy_id","subj":"T5","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"f COVID-19.\n• Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high"}
LitCovid-sample-Pubtator
{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"11","span":{"begin":2,"end":10},"obj":"Disease"},{"id":"20","span":{"begin":15,"end":26},"obj":"Chemical"},{"id":"17","span":{"begin":36,"end":39},"obj":"Gene"},{"id":"19","span":{"begin":63,"end":71},"obj":"Species"},{"id":"21","span":{"begin":77,"end":85},"obj":"Disease"}],"attributes":[{"id":"A11","pred":"pubann:denotes","subj":"11","obj":"MESH:C000657245"},{"id":"A20","pred":"pubann:denotes","subj":"20","obj":"MESH:C502936"},{"id":"A17","pred":"pubann:denotes","subj":"17","obj":"Gene:3569"},{"id":"A19","pred":"pubann:denotes","subj":"19","obj":"Tax:9606"},{"id":"A21","pred":"pubann:denotes","subj":"21","obj":"MESH:C000657245"}],"text":"f COVID-19.\n• Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high"}
LitCovid-sample-UniProt
{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T45","span":{"begin":36,"end":39},"obj":"Protein"}],"attributes":[{"id":"A45","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q9XT80"},{"id":"A46","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q9UCU4"},{"id":"A47","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q9UCU3"},{"id":"A48","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q9UCU2"},{"id":"A49","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q9MZR1"},{"id":"A50","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q9MYZ7"},{"id":"A51","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q95KN6"},{"id":"A52","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q95181"},{"id":"A53","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q90YI0"},{"id":"A54","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q8MKH0"},{"id":"A55","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q8BN26"},{"id":"A56","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q865X6"},{"id":"A57","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q865W7"},{"id":"A58","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q6V919"},{"id":"A59","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q6L6X6"},{"id":"A60","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q5I6E3"},{"id":"A61","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q3UCQ0"},{"id":"A62","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q2MH06"},{"id":"A63","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q28819"},{"id":"A64","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q28747"},{"id":"A65","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q28319"},{"id":"A66","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q25BC2"},{"id":"A67","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q0PW36"},{"id":"A68","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q0GGL7"},{"id":"A69","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q08DT2"},{"id":"A70","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P79341"},{"id":"A71","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P51494"},{"id":"A72","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P46650"},{"id":"A73","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P41693"},{"id":"A74","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P41683"},{"id":"A75","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P41323"},{"id":"A76","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P29455"},{"id":"A77","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P26893"},{"id":"A78","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P26892"},{"id":"A79","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P20607"},{"id":"A80","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P08505"},{"id":"A81","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/P05231"},{"id":"A82","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/O46568"},{"id":"A83","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/O35736"},{"id":"A84","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/O19007"},{"id":"A85","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/B6CKP4"},{"id":"A86","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/A9QWQ9"},{"id":"A87","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/A3FBE9"},{"id":"A88","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/A0S0B0"}],"text":"f COVID-19.\n• Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high"}
LitCovid-sample-Enju
{"project":"LitCovid-sample-Enju","denotations":[{"id":"T74","span":{"begin":2,"end":10},"obj":"NN"},{"id":"T75","span":{"begin":12,"end":13},"obj":"IN"},{"id":"T76","span":{"begin":15,"end":26},"obj":"NNP"},{"id":"T77","span":{"begin":26,"end":27},"obj":"-COMMA-"},{"id":"T78","span":{"begin":28,"end":30},"obj":"DT"},{"id":"T79","span":{"begin":31,"end":39},"obj":"NN"},{"id":"T80","span":{"begin":39,"end":40},"obj":"-COMMA-"},{"id":"T81","span":{"begin":41,"end":44},"obj":"MD"},{"id":"T82","span":{"begin":45,"end":51},"obj":"VB"},{"id":"T83","span":{"begin":52,"end":59},"obj":"NN"},{"id":"T84","span":{"begin":60,"end":62},"obj":"IN"},{"id":"T85","span":{"begin":63,"end":71},"obj":"NNS"},{"id":"T86","span":{"begin":72,"end":76},"obj":"IN"},{"id":"T87","span":{"begin":77,"end":85},"obj":"NN"},{"id":"T88","span":{"begin":86,"end":89},"obj":"CC"},{"id":"T89","span":{"begin":90,"end":94},"obj":"JJ"}],"relations":[{"id":"R69","pred":"arg1Of","subj":"T82","obj":"T75"},{"id":"R70","pred":"arg1Of","subj":"T76","obj":"T77"},{"id":"R71","pred":"arg2Of","subj":"T79","obj":"T77"},{"id":"R72","pred":"arg1Of","subj":"T79","obj":"T78"},{"id":"R73","pred":"arg1Of","subj":"T82","obj":"T80"},{"id":"R74","pred":"arg1Of","subj":"T76","obj":"T81"},{"id":"R75","pred":"arg2Of","subj":"T82","obj":"T81"},{"id":"R76","pred":"arg1Of","subj":"T76","obj":"T82"},{"id":"R77","pred":"arg2Of","subj":"T83","obj":"T82"},{"id":"R78","pred":"arg1Of","subj":"T82","obj":"T84"},{"id":"R79","pred":"arg2Of","subj":"T85","obj":"T84"},{"id":"R80","pred":"arg1Of","subj":"T85","obj":"T86"},{"id":"R81","pred":"arg2Of","subj":"T88","obj":"T86"},{"id":"R82","pred":"arg1Of","subj":"T87","obj":"T88"}],"text":"f COVID-19.\n• Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high"}
LitCovid-sample-PD-MONDO
{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T4","span":{"begin":2,"end":10},"obj":"Disease"},{"id":"T5","span":{"begin":77,"end":85},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"f COVID-19.\n• Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high"}